Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody productionJulia Holstein, Christian Möbs, Farzan Solimani et al.|Journal of Allergy and Clinical Immunology|2020Cited by 95
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo NodularisSonja Ständer, Tamas Almadi, Athanasios Tsianakas et al.|JAMA Dermatology|2024Cited by 57
Ca <sup>2+</sup> signalling is critical for autoantibody‐induced blistering of human epidermis in pemphigus*Thomas Schmitt, Jens Waschke, Desalegn Tadesse Egu et al.|British Journal of Dermatology|2021Cited by 38
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus VulgarisDario Didona, Michael Hertl, Luca Scarsella et al.|Journal of Investigative Dermatology|2023Cited by 14